Perioperative management of new oral anticoagulants in patients undergoing elective surgery at a tertiary hospital
Increasing numbers of patients receiving new oral anticoagulants (NOAC) are undergoing elective surgery. The extent to which perioperative interruption of NOAC therapy and use of bridging heparin are concordant with best evidence is uncertain.
No Supplementary Data
No Article Media